Direktorat Registrasi ObatValid

CEFOTAXIME SODIUM

Claim this product
BPOM Number
GKL0122232144A1
Approved
21 November 2024
Expiry
31 December 2022
Form
SERBUK INJEKSI; 1 G/VIAL

About This Registration

CEFOTAXIME SODIUM is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL0122232144A1. Its current registration status is Valid, with the licence valid until 31 December 2022. The product is registered to SANBE FARMA and manufactured by SANBE FARMA - INDONESIA. BPOM first approved this registration in August 2018. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application
Registrasi Obat
Packaging
DUS,VIAL 1 G + 1 AMP PEL 4 ML
Department
Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

Ingredients (1)

CEFOTAXIME SODIUM

Market Intelligence

Owner Portfolio
SANBE FARMA holds 554 BPOM registrations
Manufacturer Scale
SANBE FARMA - INDONESIA produces 490 registered products
Registration Age
Registered for 8 years, 1 month
Expiry Status
Expired 1365 days ago

FDA Cross-Reference

via openFDA
Generic Name
CEFOTAXIME INJECTION
Product Type
HUMAN PRESCRIPTION DRUG
Route of Administration
INTRAMUSCULAR

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product
1